Intravenous Fluid Therapy in Hospitals

Physician Knowledge Level of Intravenous Fluid Therapy in Hospitals: A Cross-Sectional Study

The administration of intravenous fluids plays a crucial role in critically ill patients to support optimal management and ensure patient safety. Knowledge and conceptual frameworks will influence a clinician's accuracy in providing intravenous fluid therapy to patients. Accurate administration of fluid therapy to patients will reduce unwanted side effects and decrease the overall treatment costs during hospitalization. Various considerations in administering intravenous fluid therapy are influenced by a clinician's level of knowledge. In Indonesia, doctors working in hospitals may have different levels of education and professional status. However, it is currently unclear whether these professional differences among doctors influence their knowledge in administering fluids to patients.

Study Overview

• Status: Recruiting
• Conditions: Knowledge Level; Intravenous Fluid Therapy
• Intervention / Treatment: Other: Questionnaire

• Study Type: Observational
• Enrollment (Estimated): 50

Contacts and Locations

• Study Contact: Name: Dita Aditianingsih; Phone Number: +618151819244; Email: ditaaditiaa@gmail.com

Study Locations

• Indonesia
  • DKI Jakarta
    • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
      • Recruiting
      • Rumah Sakit Cipto Mangunkusumo
      • Contact: Dita Aditianingsih, M.D., Ph.D

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

• Anesthesia specialists
• Anesthesiologist residencies

Description

Inclusion Criteria:

• All anesthesiologist residencies and are willing to complete the questionnaire.
• All anesthesia specialists and subspecialists and are willing to complete the questionnaire until finished.

Exclusion Criteria:

• All doctors who are unwilling and do not complete the survey questionnaire.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Anesthesia Specialists	Other: Questionnaire; This questionnaire consists of (five) main parts. The first part is about personal information, the second part is about fluid administration in various settings (emergency room, operating room, and intensive care unit), the third part is about fluid administration behaviors, the fourth part is about workplace location, and the fifth part is about a case study. Filling out this questionnaire will take approximately 60 minutes of your time.
Anesthesiologist residencies	Other: Questionnaire; This questionnaire consists of (five) main parts. The first part is about personal information, the second part is about fluid administration in various settings (emergency room, operating room, and intensive care unit), the third part is about fluid administration behaviors, the fourth part is about workplace location, and the fifth part is about a case study. Filling out this questionnaire will take approximately 60 minutes of your time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Questionnaire regarding Physician Knowledge Level of Intravenous fluid therapy	Intravenous Fluid Therapy knowledge Scoring The principle for scoring these scales is the same in all cases: Estimate the average of the items that contribute to the scale; this is the raw score. Calculating the raw score=(I1+I2+I3+…+In)/n.; Use a linear transformation to standardize the raw score, so that scores range from 0 to 100; a higher score represents a higher ("better") level of knowledge. Formula use for standardization: Knowledge Score = {1-(Raw score-1)/range} X100 The maximum score is 100 (better outcome) The minimum score is 0 (worse outcome) All the information related to intravenous fluid therapy is divided into five domains: (1) basic knowledge about electrolyte fluids, (2) intravenous fluid administration, (3) intravenous fluid composition, (4) fluid resuscitation, and (5) assessment of fluid volume status.	one day

Collaborators and Investigators

• Sponsor: Indonesia University
• Investigators: Principal Investigator: Dita Aditianingsih, Indonesia University

Publications and helpful links

General Publications

• Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016 Dec;6(1):111. doi: 10.1186/s13613-016-0216-7. Epub 2016 Nov 17.
• Mackenzie DC, Noble VE. Assessing volume status and fluid responsiveness in the emergency department. Clin Exp Emerg Med. 2014 Dec 31;1(2):67-77. doi: 10.15441/ceem.14.040. eCollection 2014 Dec.
• Malbrain MLNG, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, De Laet I, Minini A, Wong A, Ince C, Muckart D, Mythen M, Caironi P, Van Regenmortel N. Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020 May 24;10(1):64. doi: 10.1186/s13613-020-00679-3.
• McDougall M, Guthrie B, Doyle A, Timmins A, Bateson M, Ridley E, Drummond G, Vadiveloo T. Introducing NICE guidelines for intravenous fluid therapy into a district general hospital. BMJ Open Qual. 2022 Feb;11(1):e001636. doi: 10.1136/bmjoq-2021-001636.
• Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol. 2018 Sep;14(9):541-557. doi: 10.1038/s41581-018-0044-0. Erratum In: Nat Rev Nephrol. 2018 Nov;14(11):717.
• Tommasino C. Fluids and the neurosurgical patient. Anesthesiol Clin North Am. 2002 Jun;20(2):329-46, vi. doi: 10.1016/s0889-8537(01)00013-x.
• Rudloff E, Hopper K. Crystalloid and Colloid Compositions and Their Impact. Front Vet Sci. 2021 Mar 31;8:639848. doi: 10.3389/fvets.2021.639848. eCollection 2021. Erratum In: Front Vet Sci. 2022 Mar 17;9:878702.

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2023
• Primary Completion (Estimated): February 1, 2024
• Study Completion (Estimated): August 1, 2024

Study Registration Dates

• First Submitted: July 18, 2023
• First Submitted That Met QC Criteria: July 26, 2023
• First Posted (Actual): July 27, 2023

Study Record Updates

• Last Update Posted (Actual): August 23, 2023
• Last Update Submitted That Met QC Criteria: August 22, 2023
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: IndonesiaUAnes047

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No